Brief: Akebia Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
22/05/2023 22:32
May 22 (Reuters) - Akebia Therapeutics Inc AKBA.O :
* AKEBIA THERAPEUTICS REGAINS COMPLIANCE WITH NASDAQ MINIMUM
BID
PRICE REQUIREMENT
Source text for Eikon: ID:nPn3Jytjfa
Further company coverage: AKBA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akebia Therapeutics
See all newsAkebia Q1 revenue falls, net income misses analyst estimates on higher expenses
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers To Its Board Of Directors
Akebia posts wider-than-expected Q4 net loss as higher expenses hurt
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule